Abstract
Human papillomavirus (HPV) variants associated with head and neck cancer generally induce a robust immune response. Despite the establishment of such an inflammatory microenvironment, HPV is able to persist and promote malignant transformation. The PD-1:PD-L1 immune checkpoint may play a critical role in the creation of an immunoprivileged site for viral persistence and the subsequent development of cancer.
Original language | English (US) |
---|---|
Article number | e24065 |
Journal | OncoImmunology |
Volume | 2 |
Issue number | 5 |
DOIs | |
State | Published - May 2013 |
Externally published | Yes |
Keywords
- HPV
- Head and neck cancer
- Immune checkpoints
- PD-1
- PD-L1
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Oncology